- Bromfenac as Adjunctive Treatment with Intravitreal Bevacizumab in Branch Retinal Vein Occlusion of Macular Edema
-
Yun JM, Cho YW, Moon JW
- KMID: 2470741
- J Korean Ophthalmol Soc.
- 2020 Feb;61(2):183-189.
- doi: 10.3341/jkos.2020.61.2.183
PURPOSE: To evaluate the effectiveness of 0.1% topical bromfenac as an adjunctive treatment with intravitreal bevacizumab (IVB) injection for branch retinal vein occlusion (BRVO) patients. METHODS: We retrospectively evaluated 68 eyes... -
- CITED
-
- Close
- SHARE
-
- Close
- Intraocular Pressure: Intravitreal Preservative-free Triamcinolone Injection in Diabetic Macular Edema and Branch Retinal Vein Occlusion
-
Lee CH, Seo YS
- KMID: 2470739
- J Korean Ophthalmol Soc.
- 2020 Feb;61(2):167-174.
- doi: 10.3341/jkos.2020.61.2.167
PURPOSE: To compare the intraocular pressure (IOP) in diabetic macular edema (DME) patients and macular edema associated with branch retinal vein occlusion (BRVO) patients after intravitreal preservative-free Triamcinolone injection. METHODS: This... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Short-term Effects of Intravitreal Injection of Three Modalities on Central Retinal Vein Occlusion
-
Jeong JS, Lee DW, Kim BS, Yoo WS, Chung IY, Park JM
- KMID: 2463358
- J Korean Ophthalmol Soc.
- 2019 Nov;60(11):1072-1079.
- doi: 10.3341/jkos.2019.60.11.1072
PURPOSE: To report the short-term effects of intravitreal bevacizumab alone, low-dose bevacizumab combined with low-dose triamcinolone injection, and intravitreal dexamethasone implant (Ozurdex®, Allergan, Irvine, CA, USA) injection in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognosis and Disorganization of Retinal Inner Layers in Central Retinal Vein Occlusion with Dexamethasone Implantation
-
Kang HJ, Cho YW, Kim BS, Jeong JS, Park JM, Chung IY, Yoo WS
- KMID: 2463356
- J Korean Ophthalmol Soc.
- 2019 Nov;60(11):1058-1063.
- doi: 10.3341/jkos.2019.60.11.1058
PURPOSE: To examine whether disorganization of retinal inner layers (DRILs) at baseline and after treatment was associated with visual acuity in patients with macular edema secondary to central retinal vein... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Epiretinal Membrane on Dexamethasone Implant for Branch Retinal Vein Occlusion Macular Edema
-
Jang M, Kim JY, Lee SY, Jeong JH, Lee EK
- KMID: 2459128
- J Korean Ophthalmol Soc.
- 2019 Sep;60(9):843-850.
- doi: 10.3341/jkos.2019.60.9.843
PURPOSE: To evaluate the effect of epiretinal membrane (ERM) on the outcomes of intravitreal dexamethasone implant (Ozurdex®, Allergan, Irvine, CA, USA) treatment for macular edema (ME) secondary to branch retinal... -
- CITED
-
- Close
- SHARE
-
- Close
- Subfoveal Choroidal Thickness Changes after Intravitreal Bevacizumab in Macular Edema Secondary to Retinal Vein Occlusion
-
Lee JY, Song SJ, Lee MY, Bae JH
- KMID: 2455456
- J Korean Ophthalmol Soc.
- 2019 Aug;60(8):740-747.
- doi: 10.3341/jkos.2019.60.8.740
PURPOSE: To determine changes in subfoveal choroidal thickness (SCT) after intravitreal injection of bevacizumab in eyes with macular edema secondary to retinal vein occlusion (RVO). METHODS: Forty-four patients treated with intravitreal... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Retinal Layer Thickness and Vascular Density between Acute and Chronic Branch Retinal Vein Occlusion
-
Oh J, Ahn J
- KMID: 2448863
- Korean J Ophthalmol.
- 2019 Jun;33(3):238-248.
- doi: 10.3341/kjo.2018.0130
PURPOSE: To compare retinal layer thickness and chorioretinal vascular density (VD) between acute and chronic branch retinal vein occlusion (BRVO). METHODS: This study included patients with BRVO. The VD of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Retinal Ganglion Cell Damage in Glaucoma and Retinal Vein Occlusion by Visual Field
-
Lee J, Jeon S, Park HY
- KMID: 2445139
- J Korean Ophthalmol Soc.
- 2019 May;60(5):455-462.
- doi: 10.3341/jkos.2019.60.5.455
PURPOSE: We analyzed and compared retinal ganglion cell damage between patients with glaucoma and those with branched retinal vein occlusion (BRVO). We performed two types of visual field examinations. METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- A Comparison of Three Intravitreal Modalities of Branch Retinal Vein Occlusion Macular Edema
-
Song H, Song HJ, Yang JH, Kim DG
- KMID: 2420331
- J Korean Ophthalmol Soc.
- 2018 Sep;59(9):834-841.
- doi: 10.3341/jkos.2018.59.9.834
PURPOSE: Short-term results regarding the efficacy of intravitreal bevacizumab, dexamethasone implants, and triamcinolone-bevacizumab in macular edema (ME) secondary to branch retinal vein occlusion (BRVO) were compared. METHODS: This study included 30... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Intravitreal Preservative-free Triamcinolone Injection for Refractory Macular Edema Secondary to Retinal Vein Occlusion
-
Lee CH, Jang MH, Seo YS
- KMID: 2418499
- J Korean Ophthalmol Soc.
- 2018 Aug;59(8):730-737.
- doi: 10.3341/jkos.2018.59.8.730
PURPOSE: To evaluate the efficacy of intravitreal preservative-free triamcinolone acetonide (Maqaid®) injection for the treatment of macular edema secondary to retinal vein occlusion (RVO) refractory to intravitreal bevacizumab injections. METHODS: This... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined Low Dose Bevacizumab-triamcinolone versus Bevacizumab Single Intravitreal Injection for Branch Retinal Vein Occlusion
-
Shin MH, Kang HJ, Seo JS, Chung IY
- KMID: 2416267
- J Korean Ophthalmol Soc.
- 2018 Jul;59(7):650-656.
- doi: 10.3341/jkos.2018.59.7.650
PURPOSE: To report the effects of combined low dose bevacizumab and low dose triamcinolone intravitreal injection compared with single bevacizumab intravitreal injection in patients with macular edema secondary to branch... -
- CITED
-
- Close
- SHARE
-
- Close
- Intraocular Pressure Changes in Patients with Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant Insertion
-
Kim J, Lee SJ, Wang DH
- KMID: 2413814
- J Korean Ophthalmol Soc.
- 2018 Jun;59(6):519-526.
- doi: 10.3341/jkos.2018.59.6.519
PURPOSE: To investigate the occurrence and increase in intraocular pressure (IOP) over time in patients with retinal vein occlusion treated with dexamethasone intravitreal implants. METHODS: Thirty-two patients who met retreatment eligibility... -
- CITED
-
- Close
- SHARE
-
- Close
- Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion
-
Moon SY, Cho KH, Woo SJ, Park SP, Kim YK
- KMID: 2402717
- Korean J Ophthalmol.
- 2018 Feb;32(1):29-37.
- doi: 10.3341/kjo.2016.0134
PURPOSE: To compare visual and anatomical outcomes of intravitreal injections of bevacizumab and dexamethasone implant (Ozurdex) treatment for macular edema associated with branch retinal vein occlusion (BRVO). METHODS: We retrospectively reviewed... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Related to Refractory Macular Edema in Branch Retinal Vein Occlusion
-
Park JH, Park JM
- KMID: 2397851
- J Korean Ophthalmol Soc.
- 2017 Dec;58(12):1367-1375.
- doi: 10.3341/jkos.2017.58.12.1367
PURPOSE: To evaluate the factors associated with refractory macular edema (ME) secondary to branch retinal vein occlusion (BRVO) after three times of intravitreal bevacizumab (IVB) injections. METHODS: Ninety eyes of Ninety... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Bevacizumab Injections for Macular Edema Secondary to Major and Macular Branch Retinal Vein Occlusion
-
Kim JY, Choi KS
- KMID: 2393165
- J Korean Ophthalmol Soc.
- 2017 Oct;58(10):1138-1144.
- doi: 10.3341/jkos.2017.58.10.1138
PURPOSE: To compare therapeutic outcome of intravitreal bevacizumab in treating macular edema between major and macular branch retinal vein occlusion (BRVO). METHODS: This retrospective, observational study included 58 eyes from 58... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of Early Visual Responses to Bevacizumab for Macular Edema in Branch Retinal Vein Occlusion
-
Ryu G, Noh D, Lee J, Sagong M
- KMID: 2388182
- J Korean Ophthalmol Soc.
- 2017 Aug;58(8):937-946.
- doi: 10.3341/jkos.2017.58.8.937
PURPOSE: To determine whether early visual acuity response to intravitreal bevacizumab in macular edema (ME) secondary to branch retinal vein occlusion (BRVO) is associated with 12-month follow-up outcome. METHODS: Sixty treatment-naïve... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Optical Coherence Tomography Angiography in Measuring the Foveal Avascular Zone Area in Patients with Branch Retinal Vein Occlusion
-
Lee S, Min JK, Woo JM
- KMID: 2387156
- J Korean Ophthalmol Soc.
- 2017 Jul;58(7):818-827.
- doi: 10.3341/jkos.2017.58.7.818
PURPOSE: To evaluate the efficacy of optical coherence tomography angiography (OCTA) by measuring the foveal avascular zone (FAZ) area in patients with branch retinal vein occlusion (BRVO). METHODS: Thirty four eyes... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion
-
Son BK, Kwak HW, Kim ES, Yu SY
- KMID: 2379877
- Korean J Ophthalmol.
- 2017 Jun;31(3):209-216.
- doi: 10.3341/kjo.2015.0158
PURPOSE: To assess the effectiveness and safety of intravitreal ranibizumab compared with bevacizumab for the treatment of macular edema associated with branch retinal vein occlusion (BRVO). METHODS: This was a retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Efficacy of Vitrectomy for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients Treated with Intravitreal Injections
-
Cho IH, Park UC, Yu HG
- KMID: 2378625
- J Korean Ophthalmol Soc.
- 2017 May;58(5):546-553.
- doi: 10.3341/jkos.2017.58.5.546
PURPOSE: To evaluate the long-term efficacy of pars plana vitrectomy (PPV) on refractory or recurrent macular edema due to branch retinal vein occlusion (BRVO) after intravitreal steroid or anti-vascular endothelial... -
- CITED
-
- Close
- SHARE
-
- Close
- Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
-
Lee KH, Kang EC, Koh HJ
- KMID: 2373466
- Korean J Ophthalmol.
- 2017 Apr;31(2):108-114.
- doi: 10.3341/kjo.2017.31.2.108
PURPOSE: To evaluate the prognostic factors and outcomes of dexamethasone intravitreal implant (DEX implant) for intravitreal bevacizumab refractory macular edema secondary to branch retinal vein occlusion (BRVO). METHODS: This was a... -
- CITED
-
- Close
- SHARE
-
- Close
